Imatinib Mesylate in Treating Patients With Myelofibrosis

Clinical trial NCT00245128 · TERMINATED

Trial details

NCT number: NCT00245128
Sponsor: OHSU Knight Cancer Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloproliferative Disorders

Start date: 2005-08-01
Primary completion: 2007-03-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.